PHAR
Pharming Group
PHAR
PHAR
4 hedge funds and large institutions have $230K invested in Pharming Group in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and closing their positions.
Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SBCM
1
Silverberg Bernstein Capital Management
Armonk,
New York
|
$196K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$6.59K |
| 3 |
3
Osaic Holdings
Scottsdale,
Arizona
|
$4.74K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SBCM
1
Silverberg Bernstein Capital Management
Armonk,
New York
| $196K | 23,435 | +5,725 | +32% |
|
2
Morgan Stanley
New York
| $23.4K | 2,800 | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $6.59K | 789 | +737 | +1,417% |
|
|
4
Osaic Holdings
Scottsdale,
Arizona
| $4.74K | 568 | +568 | New |
|
|
CFGS
5
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|